Thus, in order to examine the involvement of the PI3K or NFκB pathways in mediating the DS-induced expression of cFLIP in the breast cancer cell lines, we analyzed the protein levels in cultures that had been treated with an individual DS variant in a combination with a pharmacological inhibitor of the respective pathway using immunofluorescence. Here, CFLAR is linked to breast cancer.